Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1651 1683
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17919677 | CLEARANCE OF SENESCENT CELLS BY ACTIVATION OF iNKT CELLS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17799851 | Regulating Activation of Fibroblasts to Prevent Fibrosis | Non-Final OA | The Regents of the University of California |
| 18600975 | METHOD FOR EVALUATING MIGRATION ABILITY OF MIGRATORY CELLS | Non-Final OA | TOPPAN HOLDINGS INC. |
| 18022234 | Materials for Tumor Inoculation in Murine Mouse Models and Uses Thereof | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17838428 | MODULATION OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE LIGASE 1 (UCHL1) EXPRESSION FOR TREATING NEUROLOGICAL DISEASE, DISORDERS, AND INJURIES ASSOCIATED WITH UPPER MOTOR NEURONS | Final Rejection | Northwestern University |
| 17407604 | Cardiac Muscle-Cell-Based Coupled Oscillator Network for Collective Computing and Related Methods | Non-Final OA | University of Virginia Patent Foundation |
| 18285220 | METHOD FOR INHIBITING TRYPSIN, AND METHOD FOR PRODUCING A CELL PREPARATION USING THE SAME | Non-Final OA | KANEKA CORPORATION |
| 18293711 | DESIGNER MEMBRANELESS ORGANELLES SEQUESTER NATIVE FACTORS FOR CONTROL OF CELL BEHAVIOR | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 19181929 | COMPOSITIONS AND METHODS FOR INDUCING OOCYTE MATURATION | Non-Final OA | Gameto, Inc. |
| 18546236 | TREATMENT OF AN IOP CONDITION | Non-Final OA | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK |
| 18021596 | 3D NEURONAL TISSUE GRAFTS USING ULTRASHORT SELF-ASSEMBLING PEPTIDE SCAFOLDS | Non-Final OA | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY |
| 18535296 | SPECIMEN CYTOLOGY SUPPORTING DEVICE AND METHOD ACCORDING TO CELL STAINING METHOD | Non-Final OA | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy